TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011